GlassScriptPhysician profile
Leah Warren
NPI 1003595703
$624.08
in general payments reported to CMS, 2019-2025
13 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $109 · 2024: $335 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $624.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $132.59 | 2023-2025 | |
| Astellas Pharma US INC | $128.39 | 2024 | Veozah |
| Sumitomo Pharma America, INC. | $92.66 | 2024-2025 | Myfembree, Gemtesa |
| Hologic Sales and Service, LLC | $47.84 | 2024-2025 | Aptima |
| Abbvie INC. | $46.41 | 2024 | |
| Myriad Women'S Health, INC. | $44.13 | 2023 | Myrisk |
| Supernus Pharmaceuticals, INC. | $24.51 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $24.51 | 2025 | Zurzuvae |
| Millicent US INC | $21.70 | 2025 | Femlyv, Intrarosa |
| Exeltis, USA INC. | $20.33 | 2025 | Slynd |
| Amgen INC. | $16.83 | 2023 | Evenity, Prolia |
| Novo Nordisk INC | $13.86 | 2023 | |
| Organon LLC | $10.32 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Warren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.